Liver function markers and haematological dynamics during acute and chronic phases of experimental Fasciola hepatica infection in cattle treated with triclabendazole

Exp Parasitol. 2022 Jul:238:108285. doi: 10.1016/j.exppara.2022.108285. Epub 2022 May 30.

Abstract

Fasciola hepatica, a worldwide-distributed liver fluke, is one of the causative agents of fasciolosis, a zoonotic disease that affects livestock and humans. In livestock, fasciolosis causes huge economic losses worldwide, reducing animal fertility, milk production, weight gain and condemnation of livers. In spite of the availability of drugs, such as triclabendazole (TCZ), for the treatment of fasciolosis, they do not necessarily prevent liver damage or parasite reinfection and can eventually increase parasite resistance. The aim of this research was to relate the hepatic function, haematological parameters, leukocyte counts in circulation and parasite egg shedding during F. hepatica acute and chronic phases of infection in cattle as well as to determine how these parameters change with TCZ-treatment of chronically infected cattle. Our results show that increased levels of serum aspartate aminotransferase (AST) and gamma glutamyltransferase (GGT) were detected in early stages of the experimental infection. Moreover, high circulating eosinophil count and plateletcrit levels were correlated with fluke number in livers from infected cattle. On the other hand, although TCZ-treatment in the chronic phase of infection reduced parasite burden and damage in the liver, it was not able to completely avoid them. In conclusion, our work sheds light into the physiopathological mechanisms induced during fluke infection in cattle, revealing the complexity of the host response to the infection, together with the effects of TCZ-treatment in chronically infected animals.

Keywords: Fasciola hepatica; Fasciolosis; Fluke; Liver; Triclabendazole.

MeSH terms

  • Animals
  • Cattle
  • Cattle Diseases* / drug therapy
  • Cattle Diseases* / parasitology
  • Fasciola hepatica*
  • Fascioliasis* / drug therapy
  • Fascioliasis* / parasitology
  • Fascioliasis* / veterinary
  • Triclabendazole / therapeutic use

Substances

  • Triclabendazole